Prostate cancer is the second leading cause of cancer death among men in the USA.
Use of robot-assisted radical prostatectomy (RARP) for the management of localized prostate cancer has increased dramatically in recent years. This review focuses on comparing quality of life following RARP versus retropubic radical prostatectomy. RARP is associated with improved perioperative outcomes, such as reduced blood loss and fewer transfusions. In addition, cancer control after RARP versus retropubic radical prostatectomy is equivalent, with similar incidences of positive surgical margins and comparable early oncological outcomes. RARP appears to provide advantages in recovery of continence, potency and quality of life compared with retropubic radical prostatectomy; however, methodological limitations exist in current literature.
Written by:
Huang KH, Carter SC, Shih YC, Hu JC. Are you the author?
Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine, University of California, LA, USA.
Reference: J Comp Eff Res. 2013 May;2(3):293-9.
doi: 10.2217/cer.13.23
PubMed Abstract
PMID: 24236628
UroToday.com Prostate Cancer Section
